TISSUE BANKING MARKET ANALYSIS

Tissue Banking Market, by Product (Media and Consumables, and Equipment), by Tissue Type (Bone, Brain & Spinal Cord, Cornea, Heart Valves, Skin, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Sep 2022
Code : CMI2600
Pages :152
Formats :
Excel and PDF
Industry : Biotechnology

Market News

Global Tissue Banking Market: Key Developments

In January 2020, LifeCell International, India\'s premier human cells tissues and genetics services provider received accreditation from the American Association of Tissue Banks (AATB) for its birth tissue products. This accreditation positions LifeCell as the first & only company not only in India but also outside the U.S. to receive this accreditation. This accreditation certifies the entire process of consent, birth tissue acquisition, processing, release, storage and distribution. Birth tissue products include the placenta, umbilical cord, and amniotic fluid. Of these the most widely used product is the placental amniotic membrane, which is used as a biological bandage for management of wounds in a variety of specialties such as podiatry, ophthalmology, burns, gynecology, general and plastic surgery. LifeCell will soon launch the product in India under the brand "Amchoplast" from its manufacturing facility in Chennai, India.